Danimer Scientific — Q1 2022 Earnings Presentation
14 slides from Danimer Scientific's earnings presentation, May 10, 2022
Slide 1: First Quarter 2022 Earnings Presentation
First Quarter 2022 Earnings Presentation May 10, 2022
Slide 2: Disclaimer
Disclaimer This presentation (“Presentation”) is for informational purposes only. This Presentation shall not constitute an offer to sell, or the solicitation of an offer to buy, any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitatio
Slide 3: Danimer's Strategic Priorities
Danimer’s Strategic Priorities Expand Capacity to Achieve Scale 1 2 3 4 5 6 Lead with Innovation to Address a Broad Range of Customer Needs Grow Customer Partnerships and Product Volume Commitments Secure Cost-Effective Inputs Attain Favorable Unit Economics to Enhance Margins Enhance Team Capabilit
Slide 4: Recent Business Highlights
Recent Business Highlights Business Highlights Continued execution of growth strategy to transform the bioplastics market PHA revenues nearly doubled driving total revenues up 12% year-over-year Expanded partnership with Kemira to commercialize biodegradable aqueous coatings Announced Hyundai Oilban
Slide 5: Kemira License & Supply Agreement
Pulp & paper market leader in aqueous coatings Global revenue of ~US$2.9 billion and 5,000 employees Kemira License & Supply Agreement Entered into exclusive license and supply agreement to commercialize PHA based aqueous coatings to be used on pulp and paper in food & beverage applications Builds o
Slide 6: Customer Partnerships & Business Development Initiatives
Customer Partnerships & Business Development Initiatives Exclusive license and supply agreement to commercialize PHA based aqueous coatings to be used on pulp and paper in food & beverage applications Collaboration to jointly develop global new market opportunities and applications for PHA, starting
Slide 7: Expand Capacity: Kentucky Facility Update – Phase II Nearing Completion
Expand Capacity: Kentucky Facility Update – Phase II Nearing Completion Facility Expansion Update: Phase I (Completed 2020): $57mm of construction costs, ~20mm lbs. of Nodax-based finished product, annually Phase II broke ground in December 2020 with start-up expected in Q2 2022E ~$128mm in total co
Slide 8: Expand Capacity: Bainbridge Greenfield Facility Update
Expand Capacity: Bainbridge Greenfield Facility Update Facility Build Out Timeline Greenfield Facility Overview Commentary Location of Greenfield site selected in Georgia due to better utilities rates and incentives Broke ground in November 2021 Some equipment has been pre-ordered to avoid higher pr
Slide 9: Q1 2022 Financial Summary
Q1 2022 Financial Summary PHA-based revenues more than doubled YoY, representing 52% of revenue vs 29% in Q1 2021 Gross profit down YoY due to product mix; lower PLA-based product sales & margin partially offset by higher PHA-based product sales at improved margins Increased headcount in R&D and SG&
Slide 10: Financial Outlook
Financial Outlook 4% PHA PHA Gross Margin Total Gross Margin SG&A & R&D as % of Sales Danimer Catalytic Technologies Profit Contribution Adjusted EBITDA 2022E Adj. EBITDA of ($45) - ($35) Million Expect 2022E Capex of $190 to $200 million(1) and year end cash balance in excess of $50 million Change
Slide 11: Forward Catalysts
Forward Catalysts Continued focus on driving operational costs down as we scale production Large and growing TAM Believed to be the only PHA product offering at commercial scale production Increasing governmental regulations on single-plastic uses Demand from blue chip multinational customers Buildi
Slide 12: Danimer Scientific
4 danimer ~ scientific
Slide 13: EBITDA and EBITDAR Reconciliation
EBITDA and EBITDAR Reconciliation
Slide 14: Adjusted Gross Profit Reconciliation
Adjusted Gross Profit Reconciliation